Topic: implantable defibrillators
The FDA cleared a new device manager platform from Medtronic that allows physicians to program compatible cardiac implants using an iPad.
Alongside a notice from the FDA, Medtronic disclosed a cybersecurity vulnerability in its defibrillators and resynchronization therapy hardware.
Cardialen raised $17 million to fund its low-energy defibrillator that aims to avoid the negative effects of high-energy shocks.
Here is Monday's medtech news of note.
Here is Wednesday's medtech news of note.
LivaNova decided to look to offload the $250 million-a-year pacemaker and defibrillator unit after concluding it no longer fits with its strategy.
Boston Scientific has received FDA approval for its Resonate line of high-voltage cardiac devices.
The FDA approved Zoll Medical’s wearable defibrillator, which automatically detects and treats ventricular arrhythmias in high-risk hospital patients.
More and more heart failure patients are needing a higher shock than the standard delivered by implantable cardioverter-defibrillators to correct their heart rhythm. This week, Biotronik launched the first ICD in the U.S. that meets this need.